Czech Republic – Medicinal product of ATC group L04AC21 with the active substance BIMEKIZUMAB
By: Pardubice Region Hospital, a.s.📍 Czech RepublicOpen
Key Information
| Reference | GB-802991-2026 |
|---|
| Deadline | Dec 18, 2026 12:00 AM |
|---|
| Estimated Value | CZK 23,120,298.00 |
|---|
| Category | Advertising & Media |
|---|
| Competition Type | ICB |
|---|
| Funding Source | Self-Funded |
|---|
| Country | Czech Republic |
|---|
| Address | Kyivská 44, Pardubice, 53003, Czech Republic |
|---|
| Published | Nov 18, 2026 |
|---|
Description
2. Procedure2.1.ProcedureTitle: Medicinal product of ATC group L04AC21 with the active ingredient BIMEKIZUMABDescription: The subject of the performance of the public contract is the provision of cont...
Full details are available after unlocking this tender.